Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaThreshold is a life sciences venture studio that focuses on building and scaling biotechnology companies from the ground up. The firm partners with leading academic institutions and scientists to translate breakthrough discoveries into therapeutic products, particularly in the fields of oncology, immunology, and precision medicine. By providing both operational expertise and seed capital, NovaThreshold aims to bridge the gap between early-stage research and clinical development. The company's model involves identifying high-potential assets and forming dedicated management teams to advance them through the pre-clinical and early clinical stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nova Threshold.